![Garry Menzel](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Garry Menzel
Directeur/Membre du Conseil chez
BLACK DIAMOND THERAPEUTICS, INC.
Fortune : 176 765 $ au 31/08/2026
Profil
Garry E.
Menzel is an Independent Director at Black Diamond Therapeutics, Inc. since 2017.
Holds director roles at Epilepsy Therapy Project and Royal College of Art.
Serves as Independent Non-Executive Director at Adaptimmune Therapeutics Plc since 2023.
Director at Roslin Cell Therapies Ltd. starting 2025.
Member-National Board at Epilepsy Foundation since 2003.
Operating Partner at GHO Capital Partners LLP since 2024.
Formerly President, Chief Executive Officer & Director at TCR² Therapeutics, Inc. from 2016 to 2023.
Managing Director at Credit Suisse Group AG in 2008.
Managing Director at The Goldman Sachs Group, Inc. in 2004.
Director at Institute for Systems Biology.
Independent Director at Stoke Therapeutics, Inc. from 2020 to 2026.
Chief Financial Officer at DaVita, Inc. from 2013 to 2015.
Chief Operating Officer at Regulus Therapeutics, Inc. from 2012 to 2013.
Chief Strategy Officer at Axcella Health, Inc. from 2015 to 2016.
Research Assistant at Smithkline Beecham Plc from 2004 to 2008.
Consultant at Bain & Co., Inc. from 1994 to 2004.
Education includes an undergraduate degree from Imperial College London in 1985, a doctorate from the University of Cambridge in 1988, and an MBA from Stanford Graduate School of Business in 1994.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 26/06/2026 | 76 664 ( 0,13% ) | 160 994 $ | 31/08/2026 | |
| 11/04/2025 | 4 117 680 ( 0,26% ) | 15 771 $ | 31/08/2026 | |
| 31/03/2026 | 0 ( -.--% ) | - $ | 31/08/2026 |
Postes actifs de Garry Menzel
| Sociétés | Poste | Début |
|---|---|---|
| BLACK DIAMOND THERAPEUTICS, INC. | Directeur/Membre du Conseil | 01/03/2017 |
| ADAPTIMMUNE THERAPEUTICS PLC | Directeur/Membre du Conseil | 01/06/2023 |
GHO Capital Partners LLP
 GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners invests in middle market companies located across the globe, primarily in Europe. The firm targets companies operating in the healthcare sector. It provides financing for buyout and growth stage capital requirements. | Private Equity Investor | 01/03/2024 |
Epilepsy Foundation
 Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Provides welfare services to people with epilepsy | Corporate Officer/Principal | 01/01/2003 |
Epilepsy Therapy Project
 Epilepsy Therapy Project The Epilepsy Therapy Project is a company based in Middleburg, VA. | Directeur/Membre du Conseil | - |
Royal College of Art
 Royal College of Art Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 17/03/2010 |
Roslin Cell Therapies Ltd.
 Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapeutics | Directeur/Membre du Conseil | 01/06/2025 |
Anciens postes connus de Garry Menzel
| Sociétés | Poste | Fin |
|---|---|---|
| STOKE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 03/06/2026 |
| TCR2 THERAPEUTICS INC. | Directeur Général | 01/01/2023 |
| ░░░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░ ░░░░░░░░░░░ | ░░░░░░░░░░ |
Formation de Garry Menzel
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
95
Relations au 1er degré
20
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 20 |
|---|---|
DaVita, Inc.
 DaVita, Inc. Medical/Nursing ServicesHealth Services Provides integrated dialysis services for patients suffering from chronic kidney failure | Health Services |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Credit Suisse Group AG
 Credit Suisse Group AG Investment Banks/BrokersFinance Provides investment banking, advisory, wealth and asset management services | Finance |
The Goldman Sachs Group, Inc.
 The Goldman Sachs Group, Inc. Investment Banks/BrokersFinance Provides investment banking, asset, wealth management and platform services | Finance |
Bain & Co., Inc.
 Bain & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Provides strategy, marketing, organization, operations, IT and M&A consulting services | Commercial Services |
Imperial College London
 Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Cambridge
 University of Cambridge Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Institute for Systems Biology
 Institute for Systems Biology Miscellaneous Commercial ServicesCommercial Services Provides integration of technology, computation, biology and medicine | Commercial Services |
Epilepsy Foundation
Epilepsy Foundation Miscellaneous Commercial ServicesCommercial Services Provides welfare services to people with epilepsy | Commercial Services |
Royal College of Art
Royal College of Art Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Regulus Therapeutics, Inc.
 Regulus Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in discovering and developing of drugs | Health Technology |
Epilepsy Therapy Project
Epilepsy Therapy Project The Epilepsy Therapy Project is a company based in Middleburg, VA. | |
Axcella Health, Inc.
 Axcella Health, Inc. BiotechnologyHealth Technology Provides first-in-class precision therapeutic solutions to diseases with a focus on restoring amino acid biology | Health Technology |
Stanford Graduate School of Business
 Stanford Graduate School of Business Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GHO Capital Partners LLP
GHO Capital Partners LLP Investment ManagersFinance GHO Capital Partners invests in middle market companies located across the globe, primarily in Europe. The firm targets companies operating in the healthcare sector. It provides financing for buyout and growth stage capital requirements. | Finance |
Adaptimmune Therapeutics Plc
 Adaptimmune Therapeutics Plc BiotechnologyHealth Technology Manufactures vaccines and cancer immunotherapy products | Health Technology |
TCR2 Therapeutics, Inc.
 TCR2 Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage cell therapy company which engages in the development of biological drugs and engineering T-cells for cancer therapy | Health Technology |
Stoke Therapeutics, Inc.
 Stoke Therapeutics, Inc. BiotechnologyHealth Technology Operates as biotechnology company focused on the development of first-in-class therapeutics that selectively increase gene expression to treat genetic diseases | Health Technology |
Black Diamond Therapeutics, Inc.
 Black Diamond Therapeutics, Inc. BiotechnologyHealth Technology Discovers and develops precision medicines for cancer | Health Technology |
Roslin Cell Therapies Ltd.
Roslin Cell Therapies Ltd. BiotechnologyHealth Technology Develops and manufactures cell and gene therapeutics | Health Technology |
